医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
VCYT · VERACYTE, INC.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
VERACYTE, INC.（VCYT）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $1.4M；高管董事有效买入 —、有效卖出 —。最近申报 2026-10-20。
买入 Bought—
卖出 Sold$1.4M
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-19 | Bhanji Muna Director | 卖出 Sell | 1,864 | $43.70 | $81K | SEC |
| 2026-09-21 | Leite John Global Chief Commercial Off | 卖出 Sell | 4,015 | $40.00 | $161K | SEC |
| 2026-09-14 | Holstein Jens Director | 卖出 Sell | 5,000 | $40.95 | $205K | SEC |
| 2026-09-04 | Chambers Rebecca Chief Financial Officer | 卖出 Sell | 3,652 | $43.10 | $157K | SEC |
| 2026-09-04 | Febbo Phillip G. Chief Scientific & Med Officer | 卖出 Sell | 13,110 | $43.05 | $564K | SEC |
| 2026-09-04 | McGuire Annie EVP, General Counsel | 卖出 Sell | 3,254 | $43.09 | $140K | SEC |
| 2026-09-01 | Bhanji Muna Director | 卖出 Sell | 1,864 | $42.97 | $80K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-09-24 | Holstein Jens Director | 7,500 | $352K | 10b5-1 |
| 2026-09-21 | Leite John Officer | 4,015 | $160K | 10b5-1 |
| 2026-09-14 | Holstein Jens Director | 5,000 | $205K | 10b5-1 |
| 2026-09-04 | Febbo Phillip G. Officer | 13,110 | $586K | 10b5-1 |
| 2026-09-04 | Chambers Rebecca Officer | 3,652 | $163K | 10b5-1 |
| 2026-09-04 | McGuire Annie Officer | 3,254 | $145K | 10b5-1 |
| 2026-09-01 | Bhanji Muna Director | 3,728 | $161K | 10b5-1 |
内部人 Insiders
Bhanji Muna、Leite John、Holstein Jens、Chambers Rebecca、Febbo Phillip G.、McGuire Annie